Contributed by Anthony J. Demetris, M.D.
PATIENT HISTORY:
Per referral report, the patient is a 26-year-old male with a clinical history of chronic Hepatitis C, cholestatic liver enzyme. Review of outside material.

Final Diagnosis (Case 61)


LIVER, NEEDLE BIOPSY -
  1. ACTIVE HEPATITIS, WITH AN PROMINENT LOBULAR COMPONENT AND FEATURES SUGGESTIVE OF A CHOLESTATIC VARIANT(MODIFIED HAI=1+0+3+1 =5/18), CONSISTENT WITH VIRAL TYPE C(See microscopic description).
  2. MILD PORTAL FIBROSIS(STAGE 1/6).
  3. NO PREVIOUS BIOPSY AVAILABLE FOR COMPARISON.

Previous Biopsies on this Patient:
None

TPIS Related Resources:
Modified HAI Grading
Liver Transplant Topics


Gross Description - Case 61


The specimen consists of three (3) consult slides with an accompanying surgical pathology report.


Microscopic Description - Case 61


(1 HE, 1 Trichrome, 1 Iron) The biopsy is small and fragmented. In most regions the normal lobular architecture appears intact, but slightly distorted because of mild portal expansion and vague intralobular regenerative changes. A few of the portal tracts show mild fibrosis and contain a mild mononuclear inflammatory cell infiltrate. Bile ducts are intact. Throughout the lobules, there is moderate to severe lobular disarray, Kupffer cell hypertrophy, mild mixed steatosis, numerous acidophilic bodies and hepatocellular swelling with regeneration. Several hepatocytes contain Mallory's-like hyaline. However, no significant lobular neutrophilia or steatotic degeneration of hepatocytes are seen. No viral inclusions, prominent pigment deposition or ground glass cells are seen. The prominent lobular component including hepatocellular swelling, spotty hepatocyte necrosis and focal Mallory's-like hyaline and the cholestatic liver injury tests suggest an acute or active lobular hepatitis, with a cholestatic component. Considering the patient history, the changes are most likely related viral hepatitis, type C. However, other and/or co- existent potential insults, such as drug or alcohol, should be excluded. The clinical history relates the presence of anti-HCV antibodies. Confirmation of HCV infection by PCR analysis may be helpful. Although the duration of hepatitis C virus infection is unknown, the clinical history relates chronic disease. Therefore, the modified hepatitis activity index will be applied. In addition, the trichrome stain reveals mild to focally mild portal fibrosis with focal regenerative change. Application of the modified HAI category is as follows: Application of the modified hepatitis activity index is as follows:

MODIFIED HEPATITIS ACTIVITY INDEX
GRADING RANGE SCORE
Periportal or periseptal interface hepatitis (piecemeal necrosis) (0-4) 1
Confluent necrosis (0-6) 0
Focal (spotty) lytic necrosis, apoptosis and focal inflammation (0-4) 3
Portal inflammation (0-4) 1
TOTAL (0-18) 5
STAGING RANGE SCORE
Fibrosis (0-6) 1


Please mail comments, corrections or suggestions to the TPIS administration at the UPMC.